Plasminogen Activation-Based Thrombolysis for Ischaemic Stroke: The Diversity of Targets may Demand New Approaches

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|12|1772-1781

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.12, 2011-11, pp. : 1772-1781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombolysis in Acute Ischaemic Stroke: A Guide to Patient Selection

By Lindley Richard I.  

CNS Drugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 539-551

Adis International

Access to resources Recommend Favorite

Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke

By Ly John V   Zavala Jorge A   Donnan Geoffrey A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1571-1581

Informa Healthcare

Access to resources Recommend Favorite

Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 2, 2013-04 ,pp. : 155-169

Bentham Science Publishers

Access to resources Recommend Favorite

Ancrod may not provide clinical benefit to patients with acute ischaemic stroke

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Thrombolysis in the Treatment of Acute Ischaemic Stroke: What are the Likely Pharmacoeconomic Consequences?

By Lindsberg P.J.   Roine R.O.   Kaste M.  

CNS Drugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 1-9

Adis International

Access to resources Recommend Favorite